SCHEMBL20182837

SCHEMBL20182837

CNC(=O)c1ccccc1C(=O)NC1c2ccccc2OCC1NC(=O)Cc1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AIMP2 Q13155 3/20 0.46
GRM7 Q14831 3/20 0.41
PSMB5 P28074 2/20 0.38
CYP2C19 P33261 4/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2D6 P10635 3/20 0.37
CYP2C9 P11712 3/20 0.37
CYP3A4 P08684 2/20 0.37
DGAT2 Q96PD7 1/20 0.37
KMT2A Q03164 1/20 0.37
SIGMAR1 Q99720 2/20 0.36
EGFR P00533 1/20 0.36
ERBB2 P04626 1/20 0.36
ALDH1A1 P00352 2/20 0.36
BRD4 O60885 1/20 0.36
RAB9A P51151 1/20 0.36
RIPK1 Q13546 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182785 0.87 AIMP2 (0.52) AIMP2GRM7PSMB5CYP2C19CYP1A2
SCHEMBL29909634 0.83 GRM7 (0.63) GRM7DGAT2BRD4
SCHEMBL21559932 0.83 GRM7 (0.63) GRM7DGAT2BRD4
SCHEMBL20182869 0.80 AIMP2 (0.56) AIMP2GRM7PSMB5CYP2C19CYP1A2
SCHEMBL20182939 0.78 PSMB5 (0.50) AIMP2PSMB5CYP2C19CYP1A2CYP2D6
SCHEMBL20182838 0.77 AIMP2 (0.51) AIMP2GRM7PSMB5CYP2C19CYP1A2
SCHEMBL20182835 0.74 GRM7 (0.62) GRM7DGAT2KMT2AALDH1A1TAS1R3
SCHEMBL20182778 0.73 AIMP2 (0.49) AIMP2GRM7PSMB5CYP2C19CYP1A2
SCHEMBL20183017 0.73 AIMP2 (0.49) AIMP2GRM7PSMB5CYP2C19CYP1A2
SCHEMBL20182998 0.72 AIMP2 (0.47) AIMP2GRM7PSMB5KMT2ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018092921-A1 MGLUR7 AGONIST COMPOUNDS FOR TREATING MGLUR7- REGULATED DISEASES, DISORDERS, OR CONDITIONS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-05-24 WO disclosed